Doxy-PEP represents the absolute latest scientific advancement in targeted sexual health infection prevention. Designed specifically to drastically reduce the incidence of bacterial STIs, this innovative protocol involves taking a specific, high-dose of the antibiotic doxycycline within 72 hours following a high-risk sexual encounter.
Extensive clinical trials demonstrate that Doxy-PEP profoundly decreases the statistical likelihood of contracting chlamydia, syphilis, and, to a varying extent, gonorrhea.
Dr. Farabi carefully evaluates your detailed clinical history and specific lifestyle risk factors to determine if integrating Doxy-PEP into your broader sexual health regimen is medically appropriate.
We provide highly detailed pharmacological instructions to ensure maximum preventative efficacy while carefully managing the complex medical risks associated with broader antibiotic stewardship and the prevention of antimicrobial resistance.
